FDA Emphasizes Benefits And Risks, Gives Containment System Warning In LPM Final Guidance
The US agency also updated its safety communication for laparoscopic power morcellators
The new guidance from the US FDA urges physicians to discuss with patients the benefits and risks of using a laparoscopic power morcellator to remove uterine fibroids, and adds some language around LPM containment systems that wasn’t included in the draft of the document.
